baber/WOPTO huggingface dataset:
Patent NZ-508632-A (NZ)
Title: Clay-free ready-mixed joint compound comprising gypsum, in-situ acidic acrylate copolymer thickener and tetra sodium pyrophosphate
Inventor: ESPINOZA THERESE A
IPC: C04B28/14
Filed: 2000-12-05
Abstract: Described is a two part joint compound which sets by hydration of calcium sulfate hemihydrate to gypsum and is clay-free.  One part includes an in-situ acidic acrylate copolymer thickener (an associative thickener) with the calcium sulfate hemihydrate, along with a non-calcium bearing phosphate set preventer.  The first part contains water, but remains unset for at least 175 days.  The second part includes a set initiator compound having a cation with a log K value greater than calcium ions.  The second part is mixed with the first part when setting is desired.
Patent NZ-512705-A (NZ)
Title: Gene therapy to promote angiogenesis
Inventor: VAN ZONNEVELD ANTON JAN
IPC: A61K38/44
Filed: 1999-12-27
Abstract: A nucleic acid delivery vehicle for enhancing or inducing angiogenesis, comprising a nucleic acid delivery vehicle and a nucleic acid molecule having a sequence coding for a protein capable of increasing nitric oxide production and at least one sequence encoding an additional angiogenesis promoting factor; and the use thereof in treating endothelial dysfunction.
Patent NZ-512716-A (NZ)
Title: Use of bupropion to treat viral diseases
Inventor: REINDLER CHRISTOPHER WILLIAM
IPC: A61K31/137
Filed: 1999-12-07
Abstract: Bupropion or a salt, solvate or enantiomer thereof is used in the manufacture of a medicament to prevent or treat herpes viral infections.
Patent NZ-513126-A (NZ)
Title: Treating aluminium alloy containing magnesium and silicon for ageing
Inventor: TUNDAL ULF
IPC: C22C21/08
Filed: 1999-02-12
Abstract: Process for treating an aluminium alloy containing 0.5 - 2.5 % by weight on alloying mixture of Magnesium and Silicon, the molar ratio of Mg / Si lying between 0.70 and 1.25, an additional amount of Si equal to approximately 1/3 of the amount of any Fe, Mn and Cr present in the alloy, and the rest being made up of aluminium and unavoidable impurities, which alloy after cooling is submitted to homogenising, preheating before extrusion, extrusion and ageing, which ageing takes place at temperatures between 160 and 220 °C.  The ageing after cooling of the extruded product is performed as a dual rate ageing operation including a first stage in which the extrusion is heated with a heating rate above 30 °C/hour to a temperature between 100 and 170 °C, a second stage in which the extrusion is heated with a heating rate between 5 and 50 °C/hour to the final hold temperature between 160 and 220 °C and in that the total ageing cycle is performed in a time between 3 and 24 hours.
Patent NZ-516979-A (NZ)
Title: Shaft seals for sealing pulverulent solids
Inventor: BAYNE CHRISTOPHER FREDERICK
IPC: F16J15/447
Filed: 2000-07-12
Abstract: Contactless sealing between low speed, (5-1500 rpm), rotary shaft (302) and wall (304) is achieved in dusty environments by enabling build-up of powdery material on facing surfaces of seal (300). Labyrinthine annular passage (L, shown with exaggerated clearances) between shaft (302) and wall (304) has minimum initial clearance of not less than 0.4 mm, however entrained powder entering passage (L) deposits in layers on facing surfaces thereof to reduce cross-section of passage (L) and fluid flow therethrough. L-section setting rings may be inserted in passage (L) at assembly to maintain correct clearances. They will deteriorate rapidly during running-in of seal (300) but may contribute to build-up of powder layers.
Patent NZ-528671-A (NZ)
Title: Use of pyridoindolone derivatives for preparing anticancer medicines
Inventor: BOURRIE BERNARD
IPC: A61P35/00
Filed: 2002-04-26
Abstract: The compound of formula (I) wherein R1 is H or a methyl or ethyl group; R2 is a methyl or ethyl group or R1 and R2 together form a (CH2)3 group; R3 is a phenyl group optionally substituted with a halogen atom or a methyl or methoxy group, or a thienyl group; R4 is a H, chlorine, or a methyl or methoxy group is used in the manufacture of a medicament as anticancer agents.
Patent NZ-533412-A (NZ)
Title: Lubricating oil compositions with improved friction properties
Inventor: WINEMILLER MARK D
IPC: C10M107/02
Filed: 2003-01-31
Abstract: Disclosed herein is a method of lubricating an internal combustion engine by lubricating the engine with a lubricant composition selected from the group of lubricants consisting of: (i) a lubricant composition comprising (a) a mixture of about 3 wt% to about 30 wt% pentaerythritol esters in a base stock wherein said lubricating composition contains more than about 18 wt% saturates; (b) 0 to 2 wt% of at least one triol ester; (c) 0.33 to about 3.3 wt% of a borated hydrocarbyl succinimide (active ingredient) and wherein the percentages are based upon the total lubricating composition; (ii) a lubricant composition comprising (a) about at least 20 wt% of one or more base stocks selected from the group consisting of Group II base stocks, Group III base stocks, and wax isomerates; (b) about at least 4 wt% of a hydrocarbyl aromatic; (c) 0.33 to 3.3 wt% of a borated hydrocarbyl succinimide (active ingredient), and wherein the percentages are based upon the total lubricating composition; and, (iii) a lubricant composition comprising (a) one or more base stocks selected from the group consisting of Group II base stock, Group III base stocks and wax isomerates; (b) an amorphous olefin copolymer; and (c) 0.33 to 3.3wt% of a borated hydrocarbyl succinimide. These compositions can provide substantial reductions in the coefficient of friction and fuel economy improving benefits when admixed to lubricating oils without deleterious effects such as instability, undesirable high viscosities and deposits. Pentaerythritol esters and optionally triol esters are added to lubricating oil compositions to provide reduced friction and improved fuel economy. Preferably the borated hydrocarbyl succinimide used in a lubricating oil composition comprising paraffinic base oil stocks are a borated polyisobutenyl succinimide ashless dispersant.
Patent NZ-535444-A (NZ)
Title: Getter device for vacuum circuit breaker
Inventor: LEUSENKAMP MARTIN BERNARDUS JO
IPC: H01H33/668
Filed: 2003-03-21
Abstract: Getter device for positioning in a vacuum interior space (12) of a vacuum circuit breaker (10), in which the getter device comprises at least one tablet (2) of getter material and the interior space (12) comprises a metal wall (13, 16, 11, 17, 19, 21) with a groove (4) in which the at least one tablet (2) can be placed. The at least one tablet (2) can be fixed by at least one depression in an edge of the groove (4), characterised in that the interior space (12) is formed by an enclosure in which a fixed contact (15, 16) and a moveable contact (13, 14) are positioned, each comprising a contact body (14, 15) and a contact pin (13, 16) connected to the contact body (14, 15), in which the groove (4) is arranged in one of the contact pins (13, 16).
Patent NZ-540351-A (NZ)
Title: NPY Y5 antagonists
Inventor: TAKENAKA HIDEYUKI
IPC: A61K31/421
Filed: 2000-11-21
Abstract: Disclosed are compounds of formula (I), wherein: X is alkylene or alkenylene, R1 is optionally substituted alkyl or cycloalkyl, R2 is H or lower alkyl, or R1 and R2 are taken together to form alkylene, n is 1 or 2, Y is OCONR7, CONR7, CSNR7, NR7CO or NR7CS, R7 is H or alkyl, and Z is optionally substituted alkyl, alkenyl, amino, alkoxy, carbocyclyl or heterocyclyl. The compounds are used for the manufacture of medicaments for use as NPY Y5 receptor antagonist, particularly as anti-obestic agents.
Patent NZ-541337-A (NZ)
Title: Tensioning sheet material
Inventor: WEIGHT PETER NOLAN
Filed: 2005-07-18
Abstract: An assembly for the tensioning of sheet material in a frame has a channel for receiving the sheet material. The channel has a longitudinal opening that is narrower than the channel and a flexible strip including longitudinal feet formations that have a greater traverse dimension than that of the opening of the channel. The feet formations are adapted to be force-fitted through the opening into the channel.
Patent NZ-543013-A (NZ)
Title: Catheter with occlusion resistant tip
Inventor: HAGGSTROM KURT
IPC: A61M25/00
Filed: 2004-06-21
Abstract: A catheter is provided that includes an elongated tubular body extending to a distal end. The tubular body has a first and a second lumen with a septum disposed therebetween. The tubular body includes a first wall that defines the first lumen and a second wall that defines the second lumen. A portion of the septum extends distally beyond the first lumen and the second lumen. The first wall includes a first wall extension that extends distally beyond the first lumen and is spaced apart from the portion of the septum. The first wall extension defines a concave surface facing the portion of the septum. Alternatively, the septum has a septum extension that extends distally beyond the first lumen and the second lumen. In alternate embodiment, the septum extension defines a first planar surface and an opposing second planar surface.
Patent NZ-544317-A (NZ)
Title: IL-17 A/F heterologous polypeptides and therapeutic uses thereof
Inventor: ARNOTT DAVID
IPC: C12N15/24
Filed: 2004-06-02
Abstract: Disclosed is a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also disclosed are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.
Patent NZ-544525-A (NZ)
Title: Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
Inventor: BRIGHTON CARL T
IPC: A61P11/00
Filed: 2004-06-09
Abstract: A device for treating diseased tissue in a human knee joint, through the application of a specific and selective electric or electromagnetic field to the diseased or injured tissue in the human knee joint, is disclosed. The method comprises: (a) one of at least two electrodes and a solenoid, which is capacitively coupled and adapted for application in the proximity of a patient's knee joint; and (b) a signal generator that has a select control that selects, based on the size of the patient's knee joint, electric signals for application to the electrodes, where the solenoid or at least one coil produces an electric field in the range of approximately 8 mV/cm to 360mV/cm and a current density range of approximately 8 µA/cm2 to 300 µA/cm2 within the synovium and articular cartilage of the patient's knee joint.
Patent NZ-544989-A (NZ)
Title: Tricyclic PARP inhibitors
Inventor: HELLEDAY THOMAS
IPC: A61K31/5517
Filed: 2004-07-23
Abstract: Disclosed is the use of a therapeutic amount of a compound of Formula I, II or III, or a pharmaceutically acceptable salt thereof, in the manufacture of a cytotoxic medicament for the treatment of a disease or condition that is caused by a genetic defect in a gene that mediates homologous recombination.
Patent NZ-552207-A (NZ)
Title: Antibacterial peptides and analogues thereof, for use as eyewash, mouth wash, ointment, disinfectant, detergent or as a solution for topical use
Inventor: BRACCI LUISA
IPC: A61P13/04
Filed: 2005-07-13
Abstract: Disclosed is a antibacterial peptide consisting of one of the following amino acid sequences from the amino to the carboxylic terminal: QEKIRVRLSA, QAKIRVRLSA, QKKIRVRLSA, KIRVRLSA, AKKIRVRLSA, QAKIRVRLSA, QKAIRVRLSA, QKKARVRLSA, QKKIAVRLSA, QKKIRARLSA, QKKIRVALSA, QKKIRVRASA, QKKIRVRLAA, QKAIRVRLSA, QRKIRVRLSA, QKRIRVRLSA, QRRIRVRLSA or a functional derivative thereof. Also disclosed is the use of the peptide for medical preperations as an antibacterial drug such as eyewash, mouth wash, ointment, or solution for topic use. Further disclosed the peptide can be used as a disinfectant and/or detergent preparation with antibacterial activity
Patent NZ-554018-A (NZ)
Title: Process for preparation of trifluoroacetyl glatiramer acetate using purified hydrobromic acid
Inventor: DOLITZKY BEN-ZION
Filed: 2005-09-09
Abstract: Disclosed is a process for obtaining trifluoroacetyl glatiramer acetate wherein during the process a batch of a mixture of polypeptides, each of which consists of alanine, gamma-benzyl glutamate, tyrosine and trifluoroacetyl lysine is deprotected with a solution of hydrobromic acid in acetic acid, the process further comprising a step of pretreatment of the solution of hydrobromic acid with a bromine scavenger in order to remove free bromine. Also disclosed is a method of analyzing the percentage of brominated tyrosine in a sample of glatiramer acetate.
Patent NZ-554326-A (NZ)
Title: Beclomethasone dipropionate (BDP) and prednisone for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation
Inventor: MCDONALD GEORGE B
IPC: A61K9/20
Filed: 2005-12-30
Abstract: Disclosed is the use of beclomethasone dipropionate (BDP) and prednisone in the manufacture of a medicament for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation in a subject, wherein said medicament is formulated to provide: a) about 1-2 mg/kg/day prednisone for about 10 days, tapering over the following 7 days to about 0.0625 mg/kg/day for the remainder of the period; and b) about 4-12 mg BDP q.i.d. for about 50 days, wherein the BDP is provided in a combination of immediate release and enteric coated forms.
Patent NZ-554385-A (NZ)
Title: 2-Acylaminothiazole derivatives having affinity for the adenosine 2A
Inventor: LARSEN MOGENS
IPC: C07D417/04
Filed: 2005-09-20
Abstract: The disclosure relates to 2-acylamino-thiazole derivative compounds of the formula (I), wherein the variables are as defined in the specification, for use as a medicament. The compounds are A2A-receptor legends and are useful in the treatment of neurological and psychiatric disorders where an A2A-receptor is implicated, particularly diseases such as Parkinson's Disease (PD), Alzheimer's Disease, Huntington's disease, cerebral ischemia, haemorrhagic stroke, neonatal ischemia and hypoxia, subarachnoid haemorrhage, traumatic brain injury, cardiac arrest, Multiple Sclerosis, depression and psychosis.
Patent NZ-562981-A (NZ)
Title: An installation comprising a wave power apparatus and a support structure therefor
Inventor: STEENSTRUP PER RESEN
IPC: F03B13/18
Filed: 2006-04-12
Abstract: A wave power apparatus (302) is disclosed. The apparatus includes a plurality of rotationally supported arms (322), each of which carries a float (324) at its free end, so that a translational movement of the float caused by a wave results in rotation of the arm. The apparatus further comprises power conversion means (128,130) for converting power transmitted from the wave to the arms into electric power, e.g. a hydraulic system. A plurality of apparatus is arranged in a row such that a wave passing the row of arms causes the arms to successively pivot with a mutual phase shift. Thereby, an even power output may be achieved, and the need for frequency converters may be reduced or eliminated. Preferably, each arm is connected to a hydraulic cylinder (328) of the hydraulic system, whereby a plurality of arms feed hydraulic medium into the hydraulic motor or motors through common hydraulic conduits (180).
Patent NZ-569940-A (NZ)
Title: Additive containing N-(n-butyl) thiophosphoric triamide for urea-based fertilizer
Inventor: SUTTON ALLEN R
IPC: C05G3/90
Filed: 2007-01-12
Abstract: Disclosed is a dry flowable additive for fertilizer comprising: a. N-(n-butyl) thiophosphoric triamide (NBPT) in the range of about 1 to 80 wt. percent, and b. Solid urea-formaldehyde polymer (UFP) in the range of about 99 to 20 wt. percent wherein the UFP is a polymethyl urea resin, and wherein the additive, when combined with the fertilizer provides reduced nitrogen loss from the soil. The additive can be mixed with dicyandiamide (DCD) in the following amounts a. NBPT in the range of about 0.40 to 15.0 wt. percent; b. DCD in the range of about 40 to 95 wt. percent; c. Silicon dioxide in the range of about 0 to wt. 3 percent; and d. Solid UFP in the range of about 3 to 15 wt. percent. The additives can be mixed with Urea ammonium nitrate (UAN) to form a fluid fertilizer composition. Also disclosed is a method for preparing a flowable additive and an additive comprising a. from about 1.0 to 30 wt. percent solid UFP, and b. from about 99.0 to 70 wt. percent DCD.
Patent NZ-572591-A (NZ)
Title: 3N-substituted 8-hydroxy-quinazolin-4-ones
Inventor: BUSH ASHLEY
IPC: A61K31/4375
Filed: 2007-04-13
Abstract: Disclosed herein is the compound 5,7-dichloro-3-(cyclopropylmethyl)-2-[(dimethylamino)methyl]-8-hydroxy-3,4-dihydroquinazolin-4-one (PB1267) and pharmaceutically acceptable salts thereof.
Patent NZ-577942-A (NZ)
Title: Hollow tubular post with a protruding region to prevent the post from moving vertically in the ground
Inventor: RICHARDSON MARK FLETCHER
IPC: A01G17/04
Filed: 2009-06-25
Abstract: Disclosed is a post having an elongate tubular hollow member with an open upper end and an open lower end. The elongate member has an upper portion and a lower ground engaging portion joined to one another. The upper portion is adapted to predominately extend above the ground and the lower ground engaging portion is adapted to be fully inserted into the ground. The lower ground engaging portion has a protruding region immediately adjacent to where the upper portion and lower ground engaging portion join together. The diameter of the protruding region is greater than the diameter of the upper portion such that the protruding region defines a lipped section that is perpendicular to the longitudinal axis of the post. The lipped section is adapted to prevent the post from moving vertically when the ground engaging portion of the post is fully inserted into and enclosed within the ground.
Patent NZ-581390-A (NZ)
Title: Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
Inventor: DIJK VAN ALBERTUS ALARD
IPC: A23C9/142
Filed: 2008-06-23
Abstract: Provided is a process to produce a composition which composition comprises: an oligosaccharide, sialyloligosaccharide in an amount of 0 to 1 wt %, and free sialic acid which process comprises subjecting a first suitable substrate to a suitable enzyme to produce an oligosaccharide, and subjecting a second suitable substrate to a sialidase to produce free sialic acid.
Patent NZ-581824-A (NZ)
Title: Natural d-limonene based cleaning composition
Inventor: OCHOMOGO MANA
IPC: C11D3/38
Filed: 2008-05-15
Abstract: Disclosed is a hard surface cleaning composition comprising:(a) 0.5 to 5% alkyl polyglucoside; (b) 0.5 to 5% ethanol;(c) 0.05 to 1% glycerol;(d) 0.01 to 0.4% lemon oil or essential oil comprising d-limonene;(e) less than 0.2% builder wherein the builder comprises a builder selected from the group consisting of alkali metal carbonate, alkali metal bicarbonate, alkali metal hydroxide, alkali metal silicate and combinations thereof;(f) water; and (g) optionally dyes, colorants, and preservatives.
Patent NZ-582231-A (NZ)
Title: Catalyst loading system and method where the the speed of a line assembly varies relative to the particulate loading rate
Inventor: FRY PAUL
IPC: B01J4/00
Filed: 2008-06-02
Abstract: Disclosed is a particulate loading apparatus to be lowered and raised within a reactor tube in a reactor for filling the reactor tube with the particulate. The particulate loading apparatus includes a loading cart configured to be positioned on a tube sheet of the reactor and a drive system mounted on the loading cart. The drive means includes a variable speed means for driving the particulate loading apparatus into and out of the reactor tube. The particulate loading apparatus includes a line assembly attached to the drive system. The variable speed means varies the speed of the line assembly in accordance with a particulate loading rate into the reactor tube. The particulate loading apparatus also includes a block portion connected to the line assembly and a number of springs mounted on the block portion positioned consecutively to form a helix-pattern.
Patent NZ-590211-A (NZ)
Title: Nasal assembly including frame with vent holes of part conic shape
Inventor: JUDSON DANIEL ROBERT
IPC: A61M16/06
Filed: 2006-10-13
Abstract: A patient interface for delivering breathable gas to a patient. The interface includes a frame (65) having a plurality of vent holes (130), each of the vent holes having a part conic shape, and a cushion to communicate with a patient's airways in use, the cushion being coupled with the frame.
Patent NZ-591450-A (NZ)
Title: Rotary fastener magazine
Inventor: SHKOLNIKOV YURY
IPC: B25C1/00
Filed: 2009-08-31
Abstract: 591450 Disclosed is a fastener driving tool (10) which may be a combustion powered tool such as a nailing tool. The tool has a housing (12) substantially enclosing a power source (14) including a reciprocating piston (16) with a driver blade (18). A nosepiece (20) is associated with the housing (12) and configured for receiving the driver blade (18) and for sequentially receiving fasteners for engagement with the driver blade (18) for driving into a workpiece. A magazine (22) is configured for retaining a supply of the fasteners and for sequentially feeding the fasteners to the nosepiece (20), the magazine (22) storing a plurality of elongate strips of the fasteners, and being configured for rotating about a longitudinal axis of the magazine (22) for providing access of fasteners in each fastener strip to the nosepiece (20). The magazine (22) has a housing (12) being generally cylindrical in shape and has a plurality of elongate, peripherally spaced, radial slots (38) extending along the longitudinal axis of the magazine.
Patent NZ-594933-A (NZ)
Title: Preparation of soy protein product using water extraction ("s803")
Inventor: SEGALL KEVIN I
IPC: A23C11/10
Filed: 2010-02-11
Abstract: Disclosed is a soy protein product which is completely soluble and is capable of providing transparent and heat stable solutions at low and neutral pH values is produced by extracting a soy protein source material with water at low pH, subjecting the resulting aqueous soy protein solution to ultrafiltration and optional diafiltration to provide a concentrated and optionally diafiltered soy protein solution, which may be dried to provide the soy protein product. The soy protein product may be used for protein fortification of, in particular, soft drinks and sports drinks, without precipitation of protein.
Patent NZ-603259-A (NZ)
Title: Meter data collection
IPC: H04J3/00
Filed: 2012-10-26
Abstract: 603259 Disclosed is a method performed in an advanced metering infrastructure system in which a collection device (116), such as a mobile collection device in a vehicle, communicates with a plurality of metering devices (114a, 114b) to retrieve data. The method includes receiving, by one of the plurality of metering devices (114a, 114b), a request message via the collection device 116. The request message comprises response parameters that comprise an endpoint identifier. The method also includes the one metering device determining, based on at least one of the response parameters in the request message, a first time slot in which to respond to the request message. The one metering device also determines a first frequency channel for responding to the request message based on at least one of the response parameters in the request message. The method further includes responding, via the one metering device associated with the endpoint identifier, to the request message during the determined first time slot and at the determined first frequency channel.